In this 5-part webinar, Patrick discusses several highly relevant topics in the drug discovery and development space. 

• In the opening segment, Patrick emphasizes the importance of innovation and collaboration between pharmaceutical companies and CROs with specialized expertise in medtech and infotech, with the goal of improving clinical success rates and accelerating time to market, particularly for COVID-19-related therapies
• In the second segment, he discusses seven mechanisms of aging that serve as potential drug targets for anti-aging therapies and highlights the healthcare and economic impacts of an aging population. 
• In the third segment, Patrick discusses the impact of recent technologies, such as CRISPR gene editing and whole genome sequencing, and the critical role of the microbiome on disease management and drug development. 
• In the fourth segment, he shares examples on how AI (artificial intelligence) is being used to more accurately diagnose and monitor therapeutic response. 
• In the final segment, he addresses the challenging issue of high drug development costs, which can prevent promising drugs from reaching the market and restrict access to therapies. He predicts these costs will decline, driven in part by the rapid growth of biosimilars and the low cost of generic drug manufacturing.